Terrence J. Adam

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	Decision rules for personalized statin treatment prescriptions over multi-objectives	2023	Pui Ying Yew Yue Liang Terrence J. Adam Julian Wolfson Peter J. Tonellato Chih‐Lin Chi
+	Performance of subgrouped proportional reporting ratios in the US Food and Drug Administration (FDA) adverse event reporting system	2023	Daniel G. Dauner Rui Zhang Terrence J. Adam Eleazar Leal Viviene Heitlage Joel F. Farley
+ PDF Chat	When text simplification is not enough: could a graph-based visualization facilitate consumers’ comprehension of dietary supplement information?	2021	Xing He Rui Zhang Jordan M. Alpert Sicheng Zhou Terrence J. Adam Aantaki Raisa Yifan Peng Hansi Zhang Yi Guo Jiang Bian
+	Discovering novel drug-supplement interactions using a dietary supplements knowledge graph generated from the biomedical literature	2021	Dalton Schutte Jake Vasilakes Anusha Bompelli Yuqi Zhou Marcelo Fiszman Hua Xu Halil Kilicoglu Jeffrey R. Bishop Terrence J. Adam Rui Zhang
+ PDF Chat	Deep Learning Approach to Parse Eligibility Criteria in Dietary Supplements Clinical Trials Following OMOP Common Data Model	2020	Anusha Bompelli Jianfu Li Yiqi Xu Nan Wang Yanshan Wang Terrence J. Adam Zhe He Rui Zhang
+	When Text Simplification Is Not Enough: Could a Graph-Based Visualization Facilitate Consumers' Comprehension of Dietary Supplement Information?	2020	Xing He Rui Zhang Jordan M. Alpert Sicheng Zhou Terrence J. Adam Aantaki Raisa Yifan Peng Hansi Zhang Jiang Bian
+	Deep Learning Approach to Parse Eligibility Criteria in Dietary Supplements Clinical Trials Following OMOP Common Data Model.	2020	Anusha Bompelli Jianfu Li Yiqi Xu Nan Wang Yanshan Wang Terrence J. Adam Zhe He Rui Zhang
+	Big Data Cohort Extraction for Personalized Statin Treatment and Machine Learning	2019	Terrence J. Adam Chih-Lin Chi
+	Comparing the Study Populations in Dietary Supplement and Drug Clinical Trials for Metabolic Syndrome and Related Disorders.	2019	Zhe He Rubina Rizvi Fan Yang Terrence J. Adam Rui Zhang
+	Computational Pharmacoepidemiology: Applied Informatics for Drug Safety.	2012	Terrence J. Adam

Common Coauthors

Coauthor	Papers Together
Rui Zhang	6
Zhe He	3
Anusha Bompelli	3
Aantaki Raisa	2
Sicheng Zhou	2
Xing He	2
Yanshan Wang	2
Hansi Zhang	2
Yifan Peng	2
Yiqi Xu	2
Jiang Bian	2
Jordan M. Alpert	2
Yi Guo	1
Marcelo Fiszman	1
Hua Xu	1
Daniel G. Dauner	1
Nan Wang	1
Nan Wang	1
Rui Zhang	1
Fan Yang	1
Yuqi Zhou	1
Julian Wolfson	1
Jianfu Li	1
Yue Liang	1
Jianfu Li	1
Chih-Lin Chi	1
Jake Vasilakes	1
Halil Kilicoglu	1
Rubina Rizvi	1
Peter J. Tonellato	1
Jeffrey R. Bishop	1
Chih‐Lin Chi	1
Eleazar Leal	1
Joel F. Farley	1
Pui Ying Yew	1
Viviene Heitlage	1
Dalton Schutte	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	A human–computer collaborative approach to identifying common data elements in clinical trial eligibility criteria	2012	Jake Luo Riccardo Miotto Chunhua Weng	2
+	Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals	2007	Harriette G.C. Van Spall Andrew Toren Alex Kiss Robert Fowler	2
+	Comparing the Study Populations in Dietary Supplement and Drug Clinical Trials for Metabolic Syndrome and Related Disorders.	2019	Zhe He Rubina Rizvi Fan Yang Terrence J. Adam Rui Zhang	2
+ PDF Chat	Clinical Trial Generalizability Assessment in the Big Data Era: A Review	2020	Zhe He Xiang D. Tang Xi Yang Yi Guo Thomas J. George Neil Charness Kelsa Bartley William R. Hogan Jiang Bian	2
+ PDF Chat	Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area	2014	Birgitta Grundmark Lars Holmberg Hans Garmo Björn Zethelius	1
+ PDF Chat	Electronic Screening Improves Efficiency in Clinical Trial Recruitment	2009	Samir R. Thadani Chunhua Weng J. Thomas Bigger John F. Ennever D. Wajngurt	1
+	Impact of Stratification on Adverse Drug Reaction Surveillance	2008	Johan Hopstadius G. Niklas Norén Andrew Bate I. Ralph Edwards	1
+	Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases	2016	Suzie Seabroke Gianmario Candore Kristina Juhlin Naashika Quarcoo A Wisniewski Ramin B. Arani Jeffery L. Painter Philip Tregunno G. Niklas Norén Jim Slattery	1
+	Optimal decision support rules improve personalize warfarin treatment outcomes	2016	Chih‐Lin Chi Kourosh Ravvaz John Weissert Peter J. Tonellato	1
+	Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)	2017	Yasser Alatawi Richard A. Hansen	1
+	Using simulation and optimization approach to improve outcome through warfarin precision treatment	2017	Chih-Lin Chi Lu He Kourosh Ravvaz John Weissert Peter J. Tonellato	1
+	C-statistic: A brief explanation of its construction, interpretation and limitations	2017	Samantha‐Jo Caetano Guru Sonpavde Gregory R. Pond	1
+	Missing Data: A Review of the Literature	1983	Andy B. Anderson Alexander Basilevsky Derek Hum	1
+	Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance	2018	Lisa Harinstein Dipti Kalra Cindy Kortepeter Mónica Muñoz Eileen Wu Gerald J. Dal Pan	1
+	Addressing Extreme Propensity Scores via the Overlap Weights	2018	Fan Li Laine Thomas	1
+ PDF Chat	BioBERT: a pre-trained biomedical language representation model for biomedical text mining	2019	Jinhyuk Lee Wonjin Yoon Sungdong Kim Donghyeon Kim Sunkyu Kim Chan Ho So Jaewoo Kang	1
+	Publicly Available Clinical BERT Embeddings	2019	Emily Alsentzer John R. Murphy Willie Boag Wei‐Hung Weng Di Jin Tristan Naumann Matthew B. A. McDermott	1
+	Transfer Learning in Biomedical Natural Language Processing: An Evaluation of BERT and ELMo on Ten Benchmarking Datasets	2019	Yifan Peng Shankai Yan Zhiyong Lu	1
+	Adam: A Method for Stochastic Optimization	2014	Diederik P. Kingma Jimmy Ba	1
+	RoBERTa: A Robustly Optimized BERT Pretraining Approach	2019	Yinhan Liu Myle Ott Naman Goyal Jingfei Du Mandar Joshi Danqi Chen Omer Levy Mike Lewis Luke Zettlemoyer Veselin Stoyanov	1
+	SUPP.AI: finding evidence for supplement-drug interactions	2020	Lucy Lu Wang Oyvind Tafjord Arman Cohan Sarthak Jain Sam Skjonsberg Carissa Schoenick Nick Botner Waleed Ammar	1
+ PDF Chat	Domain-Specific Language Model Pretraining for Biomedical Natural Language Processing	2021	裕二池谷 Robert Tinn Hao Cheng Michael Lucas Naoto Usuyama Xiaodong Liu Tristan Naumann Jianfeng Gao Hoifung Poon	1
+	Drug repurposing for COVID-19 via knowledge graph completion	2021	Rui Zhang Dimitar Hristovski Dalton Schutte Andrej Kastrin Marcelo Fiszman Halil Kilicoglu	1
+	Bidirectional LSTM-CRF Models for Sequence Tagging	2015	Zhiheng Huang Wei Xu Kai Yu	1
+ PDF Chat	N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects	2020	Frances A. Wood James P. Howard Judith A. Finegold Alexandra N. Nowbar David Thompson Ahran Arnold Christopher Rajkumar Susan Connolly Jaimini Cegla Chris Stride	1
+	Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports	2001	Stephen Evans Patrick Waller Sarah Davis	1
+	An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies	2011	Peter C. Austin	1
+	The Clinical Trials Transformation Initiative (CTTI).	2011	Alberto Grignolo	1